prmt proteins Search Results


anti prmt6  (TargetMol)
91
TargetMol anti prmt6
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG <t>or</t> <t>anti‐PRMT6</t> antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Anti Prmt6, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti prmt6/product/TargetMol
Average 91 stars, based on 1 article reviews
anti prmt6 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
sirna specific for human prmt (protein arginine methyltransferase)  (Qiagen)
90
Qiagen sirna specific for human prmt (protein arginine methyltransferase)
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG <t>or</t> <t>anti‐PRMT6</t> antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Sirna Specific For Human Prmt (Protein Arginine Methyltransferase), supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna specific for human prmt (protein arginine methyltransferase)/product/Qiagen
Average 90 stars, based on 1 article reviews
sirna specific for human prmt (protein arginine methyltransferase) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
anti-protein arginine methyltransferases (prmt)-1 (1:200)  (EpiGentek)
90
EpiGentek anti-protein arginine methyltransferases (prmt)-1 (1:200)
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG <t>or</t> <t>anti‐PRMT6</t> antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Anti Protein Arginine Methyltransferases (Prmt) 1 (1:200), supplied by EpiGentek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-protein arginine methyltransferases (prmt)-1 (1:200)/product/EpiGentek
Average 90 stars, based on 1 article reviews
anti-protein arginine methyltransferases (prmt)-1 (1:200) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
protein arginine methyltransferases (prmt)  (Epigenomics ag)
90
Epigenomics ag protein arginine methyltransferases (prmt)
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG <t>or</t> <t>anti‐PRMT6</t> antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Protein Arginine Methyltransferases (Prmt), supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein arginine methyltransferases (prmt)/product/Epigenomics ag
Average 90 stars, based on 1 article reviews
protein arginine methyltransferases (prmt) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
protein arginine methyltransferase (prmt)  (Helmholtz Zentrum fur Infektionsforschung GmbH)
90
Helmholtz Zentrum fur Infektionsforschung GmbH protein arginine methyltransferase (prmt)
Assembly sequence of the <t>PRMT6/PARP1/CRL4B</t> complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG <t>or</t> <t>anti‐PRMT6</t> antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.
Protein Arginine Methyltransferase (Prmt), supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein arginine methyltransferase (prmt)/product/Helmholtz Zentrum fur Infektionsforschung GmbH
Average 90 stars, based on 1 article reviews
protein arginine methyltransferase (prmt) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Assembly sequence of the PRMT6/PARP1/CRL4B complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.

Journal: Advanced Science

Article Title: The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis

doi: 10.1002/advs.202202737

Figure Lengend Snippet: Assembly sequence of the PRMT6/PARP1/CRL4B complex. A) Lysates from PRMT6‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. B) Lysates from PARP1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. C) Lysates from CUL4B‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. D) Lysates from DDB1‐knockdown MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. E) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PRMT6 antibody, followed by immunoblotting with indicated antibodies. F) Lysates from MDA‐MB‐231 cells with Olaparib treatment immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. G) Lysates from PRMT6‐overexpressing PRMT6 MDA‐MB‐231 cells treated with EPZ020411 immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. H) Lysates from MDA‐MB‐231 cells immunoprecipitated with control IgG or an anti‐PARP1 antibody, followed by immunoblotting with indicated antibodies. I) Western blot analysis of the indicated chromatin modifications in stably overexpressing PRMT6 MDA‐MB‐231 cells. J) Schematic diagram depicting the assembled sequence of the PRMT6/PARP1/CRL4B complex.

Article Snippet: The antibodies were listed as follows: anti‐FLAG (F1408), anti‐CUL4B (C9995), anti‐ β ‐actin (A1978), anti‐HDAC1 (H3284), anti‐HDAC2 (H3159), anti‐Vimentin (V6630) and anti‐Fibronectin (F3648) from Sigma‐Aldrich; anti‐DDB1 (sc‐25367) and anti‐PER1 (sc‐398890) from Santa Cruz Biotechnology; anti‐ROC1 (ab2977), anti‐H3 (ab1791), anti‐H4 (ab17840), anti‐H3R2me2a (ab194706), anti‐H3R2me2s (ab194684), anti‐H4R3me2s (ab5823), antiH4R3me2a (ab129231), anti‐H3R8me2s (ab130740), anti‐H3R8me2a (ab127163), anti‐H3K4me2 (ab32356), anti‐H3K36me1 (ab176920), anti‐H3K36me2 (ab176921), and anti‐H3K36me3 (ab194677) from Abcam; anti‐H2AK119ub1 (05‐678) from Millipore; anti‐ α ‐catenin (610193), anti‐ γ ‐catenin (610253), anti‐E‐cadherin (610181), and anti‐N‐cadherin (610920) from BD Bioscience; anti‐PRMT6 (14641S), anti‐PARP1 (9532T), and anti‐HER2 (4290) from Cell Signaling Technology; anti‐PER3 (12550‐1‐AP), anti‐LDHA (21799‐1‐AP), anti‐BHLHE40 (17895‐1‐AP), and anti‐CSNK1A1 (55192‐1‐AP) from Proteintech; anti‐PRMT6 (sc‐271744), anti‐PARP1 (sc‐8007), and anti‐PER3 (sc‐517227) from Santa; PARP inhibitor Olaparib (T3015) and Veliparib (T2591) and PRMT6 inhibitor EPZ020411 (T4334) from Topscience; small interfering RNAs targeting human PRMT6 (esiRNAs) (EHU125311) from Sigma‐Aldrich.

Techniques: Sequencing, Knockdown, Immunoprecipitation, Control, Western Blot, Stable Transfection